HCA Healthcare, Inc.
Michael J Schlosser (EVP and Chief Clinical Officer) reports HCA insider transactions
AI-generated summary
Michael J Schlosser, EVP and Chief Clinical Officer, acquired 4,928 shares of Common Stock for a total value of $405,588.10 by exercising or converting derivatives. Additionally, 2,455 shares of Common Stock were disposed for tax withholding valued at $1,173,686.40. After these transactions, the insider directly held 2,643.1027 shares of Common Stock.
Key facts
- Insider
- Michael J Schlosser · EVP and Chief Clinical Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | M · exercise or conversion of a derivative | +3,030 | $81.96 | $248,338.80 | 3,200.1027 | Direct |
| Oct 29, 2026 | M · exercise or conversion of a derivative | +1,898 | $82.85 | $157,249.30 | 5,098.1027 | Direct |
| Oct 29, 2026 | F · tax withholding | −2,455 | $478.08 | $1,173,686.40 | 2,643.1027 | Direct |
| Oct 29, 2026 | M · exercise or conversion of a derivativeStock Appreciation RightFootnotes F1 | −3,030 | $0.00 | $0.00 | 0 | Direct |
| Oct 29, 2026 | M · exercise or conversion of a derivativeStock Appreciation RightFootnotes F2 | −1,898 | $0.00 | $0.00 | 0 | Direct |
| Oct 29, 2026 | A · grantStock Appreciation RightFootnotes F3 | +2,797 | $0.00 | $0.00 | 2,797 | Direct |
Footnotes
- F1 The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
- F2 The stock appreciation rights vested in four equal annual installments beginning on May 3, 2018.
- F3 The stock appreciation rights vest in four equal annual installments beginning on October 29, 2027.
More HCA filings
- 8-K
Filed Nov 2, 2026
- 424B3
Filed Nov 2, 2026
- 10-Q
Filed Oct 29, 2026
- 144
Filed Oct 29, 2026
- 8-K
Filed Oct 27, 2026
- 3
Filed Sep 11, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.